Olivia Erin Macapili Buenafe

Dr. Olivia Erin Macapili Buenafe

Ateneo de Manila University, Quezon City, Quezon, Philippines
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TATatiana Afrikanova
Tatiana Afrikanova
ASAnn-Sophie K Serruys
Ann-Sophie K Serruys
OBOlivia Erin Macapili Buenafe
Olivia Erin Macapili Buenafe
RCRalph Clinckers
Ralph Clinckers
ISIlse Smolders
Ilse Smolders
CECamila Esguerra
Camila Esguerra
Zebrafish have recently emerged as an attractive in vivo model for epilepsy. Seven-day-old zebrafish larvae exposed to the GABAA antagonist pentylenetetrazol (PTZ) exhibit increased locomotor activity, seizure-like behavior, and epileptiform electrographic activity. A previous study showed that 12 out of 13 antiepileptic drugs (AEDs) suppressed PTZ-mediated increases in larval movement, indicating the potential utility of zebrafish as a high-throughput in vivo model for AED discovery. However, a question remained as to whether an AED-induced decrease in locomotion is truly indicative of anticonvulsant activity, as some drugs may impair larval movement through other mechanisms such as general toxicity or sedation. We therefore carried out a study in PTZ-treated zebrafish larvae, to directly compare the ability of AEDs to inhibit seizure-like behavioral manifestations with their capacity to suppress epileptiform electrographic activity. We re-tested the 13 AEDs of which 12 were previously reported to inhibit convulsions in the larval movement tracking assay, administering concentrations that did not, on their own, impair locomotion. In parallel, we carried out open-field recordings on larval brains after treatment with each AED. For the majority of AEDs we obtained the same response in both the behavioral and electrographic assays. Overall our data correlate well with those reported in the literature for acute rodent PTZ tests, indicating that the larval zebrafish brain is more discriminatory than previously thought in its response to AEDs with different modes of action. Our results underscore the validity of using the zebrafish larval locomotor assay as a rapid first-pass screening tool in assessing the anticonvulsant and/or proconvulsant activity of compounds, but also highlight the importance of performing adequate validation when using in vivo models.

17 October 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JMJan Maes
Jan Maes
LVLien Verlooy
Lien Verlooy
OBOlivia Erin Macapili Buenafe
Olivia Erin Macapili Buenafe
PWPeter de Witte
Peter de Witte
CECamila Esguerra
Camila Esguerra
ACAlexander D. Crawford
Alexander D. Crawford
Zebrafish are rapidly growing in popularity as an in vivo model system for chemical genetics, drug discovery, and toxicology, and more recently also for natural product discovery. Experiments involving the pharmacological evaluation of small molecules or natural product extracts in zebrafish bioassays require the effective delivery of these compounds to embryos and larvae. While most samples to be screened are first solubilized in dimethyl sulfoxide (DMSO), which is then diluted in the embryo medium, often this method is not sufficient to prevent the immediate or eventual precipitation of the sample. Certain compounds and extracts are also not highly soluble in DMSO. In such instances the use of carriers and/or other solvents might offer an alternative means to achieve the required sample concentration. Towards this end, we determined the maximum tolerated concentration (MTC) of several commonly used solvents and carriers in zebrafish embryos and larvae at various developmental stages. Solvents evaluated for this study included acetone, acetonitrile, butanone, dimethyl formamide, DMSO, ethanol, glycerol, isopropanol, methanol, polyethylene glycol (PEG-400), propylene glycol, and solketal, and carriers included albumin (BSA) and cyclodextrin (2-hydroxypropyl-beta-cyclodextrin, or HPBCD). This study resulted in the identification of polyethylene glycol (PEG400), propylene glycol, and methanol as solvents that were relatively well-tolerated over a range of developmental stages. In addition, our results showed that acetone was well-tolerated by embryos but not by larvae, and 1% cyclodextrin (HPBCD) was well-tolerated by both embryos and larvae, indicating the utility of this carrier for compound screening in zebrafish. However, given the relatively small differences (2–3 fold) between concentrations that are apparently safe and those that are clearly toxic, further studies – e.g. omics analyses –should be carried out to determine which cellular processes and signalling pathways are affected by any solvents and carriers that are used for small-molecule screens in zebrafish.

12 August 2013 in ACS Chemical Neuroscience
Verified
Journal Article
Open access
OBOlivia Erin Macapili Buenafe
Olivia Erin Macapili Buenafe
AOAdriana Orellana-Paucar
Adriana Orellana-Paucar
JMJan Maes
Jan Maes
HHHao Huang
Hao Huang
XYXuhui Ying
Xuhui Ying
PWPeter de Witte
Peter de Witte
Danshen or Chinese red sage (Salvia miltiorrhiza, Bunge) is used by traditional Chinese medicine (TCM) practitioners to treat neurological, cardiovascular, and cerebrovascular disorders and is included in some TCM formulations to control epileptic seizures. In this study, acetonic crude extracts of danshen inhibited pentylenetetrazol (PTZ)-induced seizure activity in zebrafish larvae. Subsequent zebrafish bioassay-guided fractionation of the extract resulted in the isolation of four major tanshinones, which suppressed PTZ-induced activity to varying degrees. One of the active tanshinones, tanshinone IIA, also reduced c-fos expression in the brains of PTZ-exposed zebrafish larvae. In rodent seizure models, tanshinone IIA showed anticonvulsive activity in the mouse 6-Hz psychomotor seizure test in a biphasic manner and modified seizure thresholds in a complex manner for the mouse i.v. PTZ seizure assay. Interestingly, tanshinone IIA is used as a prescription drug in China to address cerebral ischemia in patients. Here, we provide the first in vivo evidence demonstrating that tanshinone IIA has anticonvulsant properties as well.

15 August 2014 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
SCSoura Challal
Soura Challal
OBOlivia Erin Macapili Buenafe
Olivia Erin Macapili Buenafe
Emerson QueirozEmerson Queiroz
Emerson Queiroz
SMSnezana Maljevic
Snezana Maljevic
LMLaurence Marcourt
Laurence Marcourt
ACAlexander D. Crawford
Alexander D. Crawford

25 June 2008 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
FDFabian Dayrit
Fabian Dayrit
OBOlivia Erin Macapili Buenafe
Olivia Erin Macapili Buenafe
ECEdward T. Chainani
Edward T. Chainani
IVIan Mitchelle S. de Vera
Ian Mitchelle S. de Vera

1 April 2015 in Epilepsy & Behavior
Verified
Journal Article
Open access
KLKarine Leclercq
Karine Leclercq
TATatiana Afrikanova
Tatiana Afrikanova
MLMelanie Langlois
Melanie Langlois
APAn De Prins
An De Prins
OBOlivia Erin Macapili Buenafe
Olivia Erin Macapili Buenafe
RKRafal M. Kaminski
Rafal M. Kaminski
Treatment-resistant seizures affect about a third of patients suffering from epilepsy. To fulfill the need for new medications targeting treatment-resistant seizures, a number of rodent models offer the opportunity to assess a variety of potential treatment approaches. The use of such models, however, has proven to be time-consuming and labor-intensive. In this study, we performed pharmacological characterization of the allylglycine (AG) seizure model, a simple in vivo model for which we demonstrated a high level of treatment resistance. (d,l)-Allylglycine inhibits glutamic acid decarboxylase (GAD) - the key enzyme in γ-aminobutyric acid (GABA) biosynthesis - leading to GABA depletion, seizures, and neuronal damage. We performed a side-by-side comparison of mouse and zebrafish acute AG treatments including biochemical, electrographic, and behavioral assessments. Interestingly, seizure progression rate and GABA depletion kinetics were comparable in both species. Five mechanistically diverse antiepileptic drugs (AEDs) were used. Three out of the five AEDs (levetiracetam, phenytoin, and topiramate) showed only a limited protective effect (mainly mortality delay) at doses close to the TD50 (dose inducing motor impairment in 50% of animals) in mice. The two remaining AEDs (diazepam and sodium valproate) displayed protective activity against AG-induced seizures. Experiments performed in zebrafish larvae revealed behavioral AED activity profiles highly analogous to those obtained in mice. Having demonstrated cross-species similarities and limited efficacy of tested AEDs, we propose the use of AG in zebrafish as a convenient and high-throughput model of treatment-resistant seizures.